K'imaw Medical Center Clinic/Center Medicare: Medicare Enrolled Practice Location: 535 Airport Rd, Hoopa, CA 95546 Phone: 530-625-4261 Fax: 530-625-9308 |
Hupa Health Association, Inc. Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 535 Airport Rd Ste 104, Hoopa, CA 95546 Phone: 530-625-4585 Fax: 530-625-4312 |
K'ima: W Medical Center Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 1200 Airportroad, Hoopa, CA 95546 Phone: 530-625-4261 Fax: 530-625-9308 |
Hupa Health Association Inc Ambulance Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 535 Airport Rd, Hoopa, CA 95546 Phone: 530-625-4261 Fax: 530-625-9308 |
News Archive
Case Western Reserve University School of Medicine has received a three-year, $1,118,556 grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health to investigate a new imaging approach for diagnosing peripheral arterial disease, a common and potentially serious circulatory problem. More than 200 million people worldwide suffer from the condition.
Researchers have developed a new fluorescence microscopy approach that significantly improves image resolution by acquiring three views of a sample at the same time. Their new method is particularly useful for watching the dynamics of biological processes, which can provide insights into how healthy cells work and what goes wrong when diseases occur.
The doors to the new, state-of-the-art emergency center at 1653 W. Congress Parkway will be the first to "open in the new hospital building at Rush University Medical Center at 6 a.m. CT on Friday, Jan. 6. Rush's current emergency department will close early Friday morning when the department goes on bypass during the move to the new facility.
Type 2 diabetes (T2D) and osteoporosis often coexist in patients, but managing both conditions can be a challenge.
BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the publication of research describing the use of HEPATOPAC® cultures with a targeted in vitro assay to identify small molecule drugs with high potential for drug-induced liver injury (DILI).
› Verified 1 days ago